(Q67509725)
Statements
A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC) (English)
A. Martoni
M. Guaraldi
M. Casadio
L. Busutti
1 December 1992
scientific article published on 01 December 1992